The use of vasopressors in Takotsubo cardiomyopathy: impact on neurological practice.
Takotsubo has been reported in a wide range of clinical conditions. The choice of vasopressors in such situations needs careful consideration. This is highlighted in the management of status epilepticus where hemodynamic compromise is often iatrogenic though this may not be the case in the presence of concomitant Takotsubo cardiomyopathy.
Rathakrishnan
Rahul
R
Lee
Yian-Ping
YP
D006801:Humans; D009422:Nervous System Diseases / Q000139:chemically induced / Q000209:etiology; D013226:Status Epilepticus / Q000139:chemically induced / Q000209:etiology; D054549:Takotsubo Cardiomyopathy / Q000150:complications / Q000188:drug therapy*; D014662:Vasoconstrictor Agents / Q000009:adverse effects / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents